Azitra, Inc. (AZTR) vs KALA BIO, Inc. (KALA)

Azitra, Inc. and KALA BIO, Inc. are both Biotechnology companies. Azitra, Inc. and KALA BIO, Inc. are of similar size ($10.7M and $10.1M). KALA BIO, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 2.5×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against −50.5%. Across the 13 metrics below, Azitra, Inc. leads on 7 and KALA BIO, Inc. on 6.

Valuation

Metric AZTR KALA Biotechnology median
P/E 2.54 n/m 7.88
P/S 5.66 0.01 11.47
P/B 0.45 0.00 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.31 n/m 0.74
EV/Sales (5.94) 7.52 10.73
Earnings yield 39.35% (6,658.33%) (28.84%)
Free cash flow yield (346.99%) (56,050.65%) (23.03%)

Profitability

Metric AZTR KALA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) (345.32%) (57.72%)
Return on assets (190.69%) (43.23%) (49.22%)
Return on invested capital (1,272.49%) (722.69%) 0.00%

Growth

Metric AZTR KALA Biotechnology median
Revenue growth (TTM) 58.18% (50.54%) 5.64%
EPS growth (last fiscal year) 85.67% 67.39% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR KALA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 6.88 4.73
Net debt to EBITDA 0.20 0.19 0.96

Dividend

Metric AZTR KALA Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric AZTR KALA Biotechnology median
Market cap 10.10m 10.73m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack